Latest US Court System Hack Is a Throwback to 2020 SolarWinds
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Hancock Whitney Second Quarter 2025 Earnings: EPS Misses Expectations
Explore Hancock Whitney's Fair Values from the Community and select yours Hancock Whitney (NASDAQ:HWC) Second Quarter 2025 Results Key Financial Results Revenue: US$360.6m (up 3.2% from 2Q 2024). Net income: US$113.0m (flat on 2Q 2024). Profit margin: 31% (down from 33% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$1.32. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Hancock Whitney EPS Misses Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.8%. Looking ahead, revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are up 1.1% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Hancock Whitney's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Bloomberg
14 minutes ago
- Bloomberg
Swiss Leaders Seek Talks With Roche, Novartis After US Tariffs
Switzerland's government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation, a spokesperson said, after the country was hit with the highest US levies in the developed world. Economy Minister Guy Parmelin and Interior Minister Elisabeth Baume-Schneider will meet top executives of the two companies for a crisis summit on the future of the Swiss pharma industry, SonntagsBlick reported on Sunday. Other producers will participate as well, the newspaper added.
Yahoo
25 minutes ago
- Yahoo
2 Surefire Stocks to Invest $1,000 in for the Long Haul
Key Points Alphabet can overcome an antitrust challenge thanks to strong growth prospects and substantial cash flow. Intuitive Surgical leads its niche of the medical device market and still has ample whitespace ahead. 10 stocks we like better than Alphabet › Investing in stocks is both accessible to the general public and likely to yield strong returns over the long term. That's what makes it one of the best ways to increase your wealth. However, putting your money in the right stocks is crucial. Some companies may turn out to be terrible investments, as they significantly lag behind the market and may even cease to exist. Investors can avoid that fate by investing in ETFs that track major indexes or by selecting stocks that have the potential to outperform broader equities over extended periods. These are typically well-established, highly profitable companies with solid businesses, excellent prospects, and strong competitive edges. Here are two brilliant examples: Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), and Intuitive Surgical (NASDAQ: ISRG). Here's why putting $1,000 into either of those stocks would be a great move. 1. Alphabet Alphabet has been one of the more undervalued among the trillion-dollar tech leaders of late. In fairness, that's because it faces some potential headwinds related to antitrust lawsuits in the U.S. Regulators want the company to relinquish its Chrome browser, a key component of its advertising business. While that's worth keeping an eye on, Alphabet continues to impress with its financial results. The company's second-quarter earnings were no different. The tech giant grew its revenue by 14% year over year to $96.4 billion, while its net earnings per share (EPS) of $2.31 were up 22.2% compared to the year-ago period. Some of Alphabet's current growth drivers, including cloud computing and artificial intelligence (AI), should remain so for many years to come. The company pointed out that its cloud division, Google Cloud, now has a revenue run rate of more than $50 billion. Though Alphabet's advertising business remains its main cash cow, cloud and AI could take over in the next decade. Investors should be excited about that since it will mean that the company will become far less reliant on its advertising business, which would take the biggest hit if Alphabet loses Chrome. So, the more diversified the business becomes, the less of a risk this potential worst-case scenario of losing Chrome is. Furthermore, Alphabet is exploring other potential opportunities, including streaming through YouTube, a leader in that niche, and self-driving cars through its subsidiary, Waymo. Lastly, Alphabet has a strong competitive edge from multiple sources, including Google's network effect and strong brand name, as well as the switching costs associated with its cloud solutions. Alphabet is firing on all cylinders, and the company's long-term prospects remain bright. Even if regulators in the U.S. succeed in forcing the company to relinquish its Chrome browser, Alphabet should recover due to having multiple lucrative opportunities and significant amounts of free cash flow -- to the tune of $5.3 billion as of the end of the second quarter. That's significantly lower than the $13.5 billion it had as of the end of Q2 2024, but that's partly because Alphabet is reinvesting substantial amounts, including a projected $85 billion this year, into capital expenditures to support various growth opportunities. This investment could pay for itself several times over in the long run as the company makes further progress in cloud, AI, and other areas. Alphabet remains well-positioned to outperform the market over the next decade. Investors can get five of the company's shares for $1,000. 2. Intuitive Surgical Intuitive Surgical, the leader in the robotic-assisted surgery (RAS) market, has struggled this year. Trump's aggressive tariffs could take a bite out of the company's earnings, which is why many investors are choosing to stay away from the stock. However, the medical device specialist's outlook is still strong, at least for investors willing to be patient. For one, Intuitive Surgical continues to record excellent financial results. The company's second-quarter revenue was $2.44 billion, 21% higher than the year-ago period, thanks to a 17% year-over-year increase in the number of procedures performed with its crown jewel, the Da Vinci System. Intuitive Surgical's adjusted EPS came in at $2.19, 23% higher than Q2 2024. The company has had little competition in the RAS field, and although that's about to change, several factors should allow it to perform well over the next decade. First, it will be challenging for newcomers to catch up, as Intuitive Surgical has been earning indications for the Da Vinci System for years. It is approved for use in general surgeries, bariatric procedures, urologic procedures, gynecologic procedures, and more. Second, since the Da Vinci System is expensive and requires a learning curve, after putting considerable time and money into acquiring one and training medical staff on it, healthcare facilities will need a lot of convincing to switch to a competitor. In other words, Intuitive Surgical benefits from high switching costs. Third, the company is an innovator. It earned clearance for the fifth generation of its crown jewel last year and will undoubtedly continue to improve the device. Lastly, there is significant whitespace in the RAS market. Intuitive Surgical will benefit from the world's aging population, as older individuals are more likely to require many of the procedures performed with its Da Vinci system. Even with the current volume of surgeries, RAS procedures have captured only 5% of those eligible for robotic surgery. That points to a massive opportunity, and as a leader in the market, Intuitive Surgical should benefit. The stock may be down this year, but it could deliver superior returns over the long run. With $1,000, investors can purchase two shares. Should you buy stock in Alphabet right now? Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,427!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,119,863!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Prosper Junior Bakiny has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Alphabet and Intuitive Surgical. The Motley Fool has a disclosure policy. 2 Surefire Stocks to Invest $1,000 in for the Long Haul was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
